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The traditional view of adipose tissue as a passive reservoir for energy storage is no
longer  valid.  As  early  as  1987,  adipose  tissue  was  identified  as  a  major  site  for
metabolism of sex steroids (1) and production of adipsin, an endocrine factor that is
markedly down-regulated in rodent obesity  (2).  The subsequent  identification and
characterization of leptin in 1994 firmly established adipose tissue as an endocrine
organ(3). Adipose tissue is now known to express and secrete a variety of bioactive
peptides, known as adipokines, which act at both the local (autocrine/paracrine) and
systemic  (endocrine)  level.  In  addition  to  these  efferent  signals,  adipose  tissue
expresses  numerous  receptors  that  allow  it  to  respond  to  afferent  signals  from
traditional  hormone  systems  as  well  as  the  central  nervous  system  (CNS).  The
important  endocrine  function  of  adipose  tissue  is  emphasized  by  the  adverse
metabolic consequences of both adipose tissue excess and deficiency. Adipose tissue
excess or obesity, particularly in the visceral compartment, is associated with insulin
resistance,  hyperglycemia,  dyslipidemia,  hypertension,  and  prothrombotic  and
proinflammatory  states  (4).  The  prevalence  of  obesity  and  these  associated
morbidities,  known  as  the  metabolic  syndrome  (MetS),  has  reached  epidemic
proportions  (4).  Interestingly,  adipose  tissue  deficiency  or  lipodystrophy  is  also
associated with features of the metabolic syndrome in both humans and rodents (5).
Metabolic syndrome (MetS) is defined as a constellation of metabolic disorders in the
same individual with frequency higher than it could be expected by chance. MetS is
one of the most widespread diseases in the world. MetS is evident in almost half of
the  population  of  specific  age  groups  in  developed countries.  The search  for  the
genetic  basis  of  complex  pathological  syndromes  represents  a  challenge  for
experimental  medicine  and  genetics.  Indeed,  the  identification  of  single  genes
involved  in  such  multifactorial  diseases  may  be  frustrating  due  to  the  intrinsic
complexity of the processes involved and of their genetic determinants and because
of the limitation of actual knowledge on gene functions and all the relative networks.
Nevertheless, we believe that the investigation on crucial cellular processes, such as
energetics,  redox  metabolism,  mitochondria-nuclei  crosstalk,  which  could  be
primarily involved in the onset of different multifactorial diseases, might allow the
identification  of  few triggering  genetic  determinants.  (6;7).  Obesity  has  a  strong
genetic  predisposition,  and  results  from an  excess  energy  intake  and/or  too  little
energy expenditure. Obesity is in most, but not all, subjects, associated with marked
changes  in  the  secretory  function  of  adipocytes  and  macrophages,  together  with
chronic low-grade inflammation and an increased risk to develop insulin resistance,
diabetes,  and/or  vascular  disease (8).  Macrophages are  more prevalent  in  adipose
tissue of obese subjects than in adipose tissue of lean subjects and the macrophage
quantity correlates with measures of insulin resistance (9). Both macrophages and
adipocytes are capable of accumulating lipids and secreting cytokines. Interestingly,
the number of macrophages in adipose tissue is reduced after weight loss (10).
Many studies showed the existence of multipotent adult progenitor cells in various
tissues MSC isolated  from tissues other than BM, as periostioum (11), trabecolar
bone (12), synovium (13), skeletal muscle (14), lung (16), thymus, spleen, pancreas,
kidney (17; 18), peripheral blood (19), umbilical cord blood (20) and placenta (21).
In the past ten years, studies reported that human adipose tissue contains a population
of multipotent stem cells (MSC) (15), isolated in large amounts from liposuction or
biopsy, and expanded in culture. Stromal-vascular cells of adipose tissue are adipose
precursor  and  their  differentiation  in  vitro   depends  on  specific  steps:  adipoblast
(unipotential  cells),  commitment  preadipose  cell  (preadipocyte),  terminal
differentiation immature adipose cell, and terminal differentiation mature adipose cell
(adipocyte)  (22)  Visceral  adipose tissue associated with Metabolic  Syndrome is  a
chemotactic niche, whereby mesenchymal stem cells can home to and differentiate
into adipocytes to perpetuate its tissue formation (23).  Our aim was to detect the
expression of  leptin, adiponectin and TNF alfa in visceral and subcutaneous adipose
tissue derived from obese (BMI ›30) and normal weight (BMI <30) patients with and
without  metabolic  syndrome  (MetS)   and  to  isolate  adipose  derived   stem  cell
(ADSC)  to analyze the expression pattern of embryonic stem cell markers in obesity
and  metabolic  syndrome. Results  suggest  that  subcutaneous  adipose  tissue  is
characterized  by   an  increased  endocrine/pro  inflammatory   activity   and  this
increment  is  more  evident  in  obese  patients  with MetS.  This  results  suggest  that
subcutaneous adipose tissue in abdominal district in presence of obesity related to
metabolic syndrome could have an intensive cytokine production. ADSCs isolated
from VAT and SAT biopsies from obese and normal weight patients express the same
levels of MSCs surfaces marker CD105 and CD-90 and embryonic stem cell markers
SSEA-4, and the expression level of CD90, CD-105 and SSEA-4 was 90%, 78% and
0,2% respectively. mRNA expression level of  pluripotency-associated genes reveals
that only Nanog is more expressed in ADSCs isolated from subcutaneous adipose
tissue  of  obese  patients  than ADSCs isolated  from visceral  adipose  tissue.  Other
pluripotency-associated  genes  as  Sox2,  Oct4,  c-Kit,  CD-90,  CD-73,  CD-105,
ABCG2, have the same expression level. Recently, a research group evidenced an
adipotaxis phenomenon in an animal model, where the MSCs of the Bone Marrow
migrated attracted to the fat depot by TNF-Alfa (245). This mechanism  supports the
idea  of   MSCs  abnormal  migration   in  patients  with  metabolic  syndromet.  We
hypothesize    that  subcutaneous  adipose  tissue  in  obese  patients  with  MetS  is
characterized by an intensive cytokine production and this may be responsible for
ADSCs migration towards subcutaneous adipose tissue and visceral adipose tissue.
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